Teva's board slashes its own compensation following massive restructuring
Teva Pharmaceuticals is making even more cuts, and this time it’s coming from the board of director’s own wallets.
The company’s board cut their cash compensation in half until further notice and Teva’s board chairman Sol Barer waives his right to cash compensation altogether, Calcalist reports.
Apparently, the decision was made back in December, before the company’s cost-cutting plans were made public, but Teva decided not to share the detail.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.